Peripheral blood minimal residual disease may replace bone marrow minimal residual disease as an immunophenotypic biomarker for impending relapse in acute myeloid leukemia
- 16 September 2015
- journal article
- Published by Springer Science and Business Media LLC in Leukemia
- Vol. 30 (3), 708-715
- https://doi.org/10.1038/leu.2015.255
Abstract
No abstract availableKeywords
This publication has 44 references indexed in Scilit:
- Defining consensus leukemia-associated immunophenotypes for detection of minimal residual disease in acute myeloid leukemia in a multicenter settingBlood Cancer Journal, 2013
- Monitoring of Minimal Residual Disease in NPM1-Mutated Acute Myeloid Leukemia: A Study From the German-Austrian Acute Myeloid Leukemia Study GroupJournal of Clinical Oncology, 2011
- Clinical significance of flowcytometric minimal residual disease detection in pediatric acute myeloid leukemia patients treated according to the DCOG ANLL97/MRC AML12 protocolLeukemia, 2010
- Monitoring of minimal residual disease in acute myeloid leukemiaCurrent Opinion in Oncology, 2009
- The use of receiver operating characteristic analysis for detection of minimal residual disease using five‐color multiparameter flow cytometry in acute myeloid leukemia identifies patients with high risk of relapseCytometry Part B: Clinical Cytometry, 2008
- Early prediction of treatment outcome in acute myeloid leukemia by measurement of WT1 transcript levels in peripheral blood samples collected after chemotherapyHaematologica, 2008
- Quantification of CBFB-MYH11 fusion gene levels in paired peripheral blood and bone marrow samples by real-time PCRLeukemia, 2005
- Revised Recommendations of the International Working Group for Diagnosis, Standardization of Response Criteria, Treatment Outcomes, and Reporting Standards for Therapeutic Trials in Acute Myeloid LeukemiaJournal of Clinical Oncology, 2003
- Monitoring minimal residual disease in peripheral blood in B‐lineage acute lymphoblastic leukaemiaBritish Journal of Haematology, 1997
- Basic principles of ROC analysisSeminars in Nuclear Medicine, 1978